This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Vincent A. Fulginiti, MD

JAMA. 1985;253(9):1302.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The report by Krober et al¹ in this issue of THE JOURNAL keeps alive the controversies that have surrounded the management of group A β-hemolytic streptococcal pharyngitis (GABS) in clinical practice. The physicians from the Tripler and Madigan Army Medical Centers have shown that early penicillin treatment resulted in significant clinical improvement when contrasted to a 72-hour delay in the initiation of penicillin treatment. This issue has also recently been addressed with the reincarnation of a study by John Nelson² performed in 1958-1959, and reported in 1984. Both studies suggest that early treatment improves clinical symptoms, despite expert statements and studies to the contrary.

The "standard" management of streptococcal pharyngitis has been a mainstay of infectious disease dogma for decades. Physicians were comfortable with the liberal use of the throat culture in children with sore throats and their contacts; in some cases of recurrent disease, even pets were . . . [Full Text PDF of this Article]

Author Affiliations
University of Arizona Health Sciences Center Tucson

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?